Study of combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet for the prevention of esophageal stricture after endoscopic submucosal dissection

Study of combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet for the prevention of esophageal stricture after endoscopic submucosal dissection - Study of combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet for the prevention of esophageal stricture after endoscopic submucosal dissection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014642

Enrollment

Registered

2014-07-25

Start date

2014-07-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

Combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient who will be performed endoscopic treatment for esophageal cancer. Absolute or relative indication of endoscopic treatment within the therapy guidelines for esophageal cancer. ESD is planned for esophageal cancer, and expected to result of a size of more than 1/2 luminal circumferencial esophageal cancer. ECOG Performance status 0-2. Aged upper 20 years old. Written informed consent.

Exclusion criteria

Exclusion criteria: Active infection. Patients with continuous systemic steroids medication. Psychosis. Patients who have been judged as inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
Rate of esophageal stricture	—

Countries

Japan

Contacts

Public ContactKunihiro Tsuji

Ishikawa prefectural central hospital Department of Gastroenterology

m92162g@ipch.jp076-237-8211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026